DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
7.95
-0.28 (-3.40%)
Feb 27, 2026, 4:00 PM EST - Market closed
DiaMedica Therapeutics Market Cap
DiaMedica Therapeutics has a market cap or net worth of $425.95 million as of February 27, 2026. Its market cap has increased by 58.64% in one year.
Market Cap
425.95M
Enterprise Value
370.90M
1-Year Change
58.64%
Ranking
Category
Stock Price
$7.95
Market Cap Chart
Since December 7, 2018, DiaMedica Therapeutics's market cap has increased from $36.70M to $425.95M, an increase of 1,060.62%. That is a compound annual growth rate of 40.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 414.00M | -0.12% |
| Dec 31, 2025 | 414.50M | 78.51% |
| Dec 31, 2024 | 232.20M | 115.40% |
| Dec 29, 2023 | 107.80M | 157.89% |
| Dec 30, 2022 | 41.80M | -57.61% |
| Dec 31, 2021 | 98.60M | -48.11% |
| Dec 31, 2020 | 190.00M | 226.46% |
| Dec 31, 2019 | 58.20M | 68.70% |
| Dec 31, 2018 | 34.50M | -5.99% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verastem | 441.48M |
| Tectonic Therapeutic | 438.90M |
| Keros Therapeutics | 432.31M |
| Entrada Therapeutics | 427.83M |
| PepGen | 427.61M |
| Immix Biopharma | 425.25M |
| LENZ Therapeutics | 422.10M |
| Century Therapeutics | 416.78M |